ArticleCancer gene therapy2022

Oncolytic adenoviruses synergistically enhance anti-PD-L1 and anti-CTLA-4 immunotherapy by modulating the tumour microenvironment in a 4T1 orthotopic mouse model.

Huan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.